Added to YB: 2024-05-24
Pitch date: 2024-05-23
TMDX [bullish]
TransMedics Group, Inc.
-8.06%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$137.91
Price Target
468.44 (+269%)
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
growth
Quality Small Caps I'm Interested In - TransMedics Group, Inc.
TMDX: Organ Care System revolutionizing transplants. Unprofitable but expanding margins while investing in growth. Focus on National OCS Program adoption, aviation ops, global expansion. Expects $1B+ revenue by 2030, 62% gross margins. Model: 242% upside (40% CAGR) to 2030 assuming conservative growth.
Read full article (2 min)